Formulations:
- Oral > Solid: 300 mg tablet (equivalent to 245 mg tenofovir disoproxil)
Indications:
- Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified
- Contact with or exposure to human immunodeficiency virus
- Chronic hepatitis B
Source: EML workbook import
Product metadata will be available once the catalog entry is complete.
Formulations:
- Oral > Solid: 300 mg tablet (equivalent to 245 mg tenofovir disoproxil)
Indications:
- Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified
- Contact with or exposure to human immunodeficiency virus
- Chronic hepatitis B
Source: EML workbook import